Log in

Caplin Point Laboratories

NSE: CAPLIPOINT · ISIN INE475E01026 · Healthcare

₹2,527.90+70.70 (+2.88%)

Monday 9 November, 12:04 IST. Delayed. Source: Yahoo Finance.

Price chart

₹2,527.90 +70.70 (+2.88%) today

The day

Previous close
₹2,457.20
Open
₹2,462.00
Day high
₹2,597.50
Day low
₹2,457.00

Listed on NSE since 23 June 2014.

Key numbers

Market value
₹18,110 Cr
P/E (trailing)
27.30
EPS (trailing)
₹87.28
Price to book
5.16
Dividend yield
0.34%
Debt to equity
0.00
Profit margin
29.1%
Beta
0.46
Volume today
1.72 L
Average volume
1.79 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹1,453.82 Cr₹376.26 Cr₹49.18
FY24₹1,679.55 Cr₹457.08 Cr₹59.90
FY25₹1,921.23 Cr₹536.31 Cr₹70.25
FY26₹2,171.38 Cr₹641.24 Cr₹84.11

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q1 FY27Apr–Jun 2026₹610 Cr₹177 Cr₹23.21+15.8%
Q4 FY26Jan–Mar 2026Audited₹600 Cr₹170 Cr₹22.31+20.8%
Q3 FY26Oct–Dec 2025₹543 Cr₹164 Cr₹21.51–
Q2 FY26Jul–Sep 2025₹534 Cr₹154 Cr₹20.25–
Q1 FY26Apr–Jun 2025₹510 Cr₹153 Cr₹20.03–
Q4 FY25Jan–Mar 2025Audited₹502 Cr₹141 Cr₹18.69–

Source: Caplin Point Laboratories’s results filed with NSE, consolidated (the whole group). Net profit is the share of Caplin Point Laboratories’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onMarch 2026September 2025March 2025
Fixed assets₹756 Cr₹700 Cr₹670 Cr
Investments₹859 Cr₹636 Cr₹590 Cr
Inventories₹429 Cr₹329 Cr₹336 Cr
Owed by customers₹826 Cr₹694 Cr₹632 Cr
Cash and equivalents₹94 Cr₹108 Cr₹199 Cr
Total assets₹4,045 Cr₹3,504 Cr₹3,209 Cr
Borrowings₹57.00 L₹49.00 L₹55.00 L
Total liabilities₹415 Cr₹305 Cr₹322 Cr
Shareholders’ equity₹3,586 Cr₹3,159 Cr₹2,850 Cr

Source: Caplin Point Laboratories’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About Caplin Point Laboratories

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel, capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, ophthalmic droppers, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Industry
Drug Manufacturers - Specialty & Generic
Based in
Chennai
Employees
4,199

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Caplin Point Laboratories in the last day or two.

Dividends and corporate actions

All companies
  • Dividend - Rs 4 Per Share

    Dividend · ex-date 18 September 2026

  • Interim Dividend - Rs 4 Per Share

    Dividend · ex-date 29 May 2026 · record date 30 May 2026

  • Dividend - Rs 3 Per Share

    Dividend · ex-date 12 September 2025

  • Interim Dividend - Rs 3 Per Share

    Dividend · ex-date 30 May 2025

  • Annual General Meeting

    Action · ex-date 23 September 2024

  • Dividend - Rs 2.50 Per Share

    Dividend · ex-date 23 September 2024

  • Interim Dividend - Rs 2.50 Per Share

    Dividend · ex-date 31 May 2024

  • Annual General Meeting/Dividend - Rs 2.50 Per Share

    Dividend · ex-date 14 September 2023

Source: NSE. Latest first, 8 of 20.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.